Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
by TimGDixon » Thu Jan 06, 2022 9:07 am
A lot of traders should have noticed a lot of things... the things you noticed.... the shorties and flippers don't notice anything but uptick/downtick... who has ears let him hear and he who has eyes let him see...
board.therapeuticsolutionsint.com/viewtopic.php?t=1459&start=10
DAMN STRAIGHT!
EXACTAMUNDO!
Prayers to your Family for total healing MayGodBePraised
"Very impressed with Mr. Dixon's professionalism, kindness, and promptness to our many questions."
When people that work with Tim say "we love Tim" They see this side of him all the time.
post these to Facebook news feed spread the word----NOW
https://www.businesswire.com/news/home/20220103005264/en/Therapeutic-Solutions-International-Reports-Positive-Clinical-Data-on-QuadraMune%C2%AE-Reduction-of-SARS-CoV-2-Spike-Protein-Induced-Inflammation
https://finance.yahoo.com/news/therapeutic-solutions-international-reports-positive-160200203.html?.tsrc=fin-srch
https://www.allpennystocks.com/specialreportsus/2831/nutraceutical-shows-promise-for-reduction-of-covid-19-spike-protein
TSOI getting MORE coverage Than before Yahoo/ all penny Spreading the good word a little farther
https://finance.yahoo.com/news/therapeutic-solutions-international-reports-positive-160200203.html?.tsrc=fin-srch
https://www.businesswire.com/news/home/20220103005264/en/Therapeutic-Solutions-International-Reports-Positive-Clinical-Data-on-QuadraMune%C2%AE-Reduction-of-SARS-CoV-2-Spike-Protein-Induced-Inflammation
https://www.allpennystocks.com/specialreportsus/2831/nutraceutical-shows-promise-for-reduction-of-covid-19-spike-protein
THE BEGINNING IS NEAR! phase III
YES NO MORE OF THAT SAVING LIVES STUFF HHUMPH SAVING 12 MEASLY LIVES LIVES, FORSOOTH.....
Happy milly BillY TRILLY New Years eve
That cannot be posted enough "Successfully treats" = winner
That was before the news.. a post to change the subject which was getting morbid
SEC probably are MMs in hiding, in plain sight...
Successfully Treats “No Option” Patients
making progress in preparing for the upcoming Phase III clinical trial
There were 12 COVID-19 patients who underwent a profound recovery despite advanced stage of disease, while the retired Navy SEAL that was previously publicly disclosed1 along with two other retired SEALS, had a significant decrease in biomarkers associated with Chronic Traumatic Encephalopathy (CTE), as well as psychological improvement at the two month follow up.
December 30, 2021 - 10:00 am
Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial
https://www.stocktitan.net/news/TSOI/therapeutic-solutions-international-successfully-treats-no-option-ijo1gh4iqqda.html
math-be-hard but work-n-hard will get it right every time
Thanks Tim G Dixon (aka THE MAN) for NanoStilbene its been a game changer health wise for me.. Kudos to TSOI and all the hard work your team brings to health alternatives for people, Its well known how the folks at TSOI feel about Tim it's " WE LOVE TIM" Cheers to Tim!
I am being holdin to both my asses YES
TSOI milly BillY freaking TRILLY TSOI
MIND THE GAP!~
TimGDixon » Tue Dec 28, 2021 5:14 pm
Thank you to everybody for all of your very generous comments which I will certainly pass on. Better get ready because lots of Ip is going to start publishing and issuing. All of these are on tap for the near future.
07-28-2020 Neuroprotection and Neuroregeneration by Pterostilbene and Compositions Thereof
07-22-2020 Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
07-13-2020 Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions
06-30-2020 Augmentation of Natural Killer Cell Activity and Induction of Cytotoxic Immunity Using Leukocyte Lysate Activated Allogeneic Dendritic Cells: StemVacs™
06-22-2020 Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity Published
06-15-2020 Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase Issued/Granted
06-11-2020 Nutraceuticals for Reducing Myeloid Suppressor Cells Published
05-11-2020 Treatment of COVID-19 Lung Injury Using Umbilical Cord Plasma Based Compositions
05-04-2020 Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19 Published
Top
you can always get QM on www.youcanordernow.com - use the code james during checkout for a 10% discount.
Therapeutic Solutions soars as nutraceutical gets patent for stimulating immune system
Dec. 28, 2021 2:40 PM ETTherapeutic Solutions International, Inc. (TSOI)By: Ravikash, SA News Editor
Therapeutic Solutions International's (OTCPK:TSOI) nutraceutical supplement QuadraMune received a patent related to stimulating the immune system by blocking immune suppressive activities used by cancer and viruses in the indolamine 2,3 deoxygenase (IDO) pathway.
The company received a Notice of Allowance from the U.S. Patent and Trademark Office regarding its patent application — Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase.
James Veltmeyer, chief medical officer and co-inventor of the patent,
https://seekingalpha.com/news/3783754-therapeutic-solutions-soars-as-nutraceutical-gets-patent-for-stimulating-immune-system?utm_source=stck.pro&utm_medium=referral
Patent for Cancer and COVID-19 Treatment
1:17 pm ET December 28, 2021 (BusinessWire) Print
Therapeutic Solutions International announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office regarding its patent application entitled "Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase."
To the knowledge of the Company, this is the first issuance of a patent on a nutraceutical supplement for stimulating the immune system by blocking immune suppressive activities used by cancer and viruses in the IDO pathway. The supplement, termed "QuadraMune(R)" is commercially available on the Company website and through Amazon.
Numerous drugs such as Optivo(R), Yervoy(R), and Keytruda(R), have been approved by the FDA for treatment of cancers by boosting immunity though blocking immune inhibiting mechanisms. This class of drugs, called "checkpoint inhibitors" represent a 15.2 billion dollar a year market(1).
"The indolamine 2,3 deoxygenase (IDO) pathway is believed to be one of the major immunological checkpoints based on the fact that small molecule blockade of this pathway results in immune mediated destruction of tumors in animals," stated Dr. Thomas Ichim, Board Member and Co-Inventor of the patent. "Unfortunately, prior approaches to suppress this pathway relied on toxic compounds which did not perform well in clinical trials, in part due to inability to administer sufficient doses without evoking toxicity. We are excited by the possibility that QuadraMune(R), a nutraceutical composition that is commercially available may act as a potent immune booster targeting the IDO pathway without drawbacks of other approaches."
In 2013(2) and subsequently in 2018(3), Dr. Ichim and colleagues published regression of breast cancer by inhibiting the IDO pathway using an RNA interference approach. The current data and patent granted are representation of years of basic scientific investigation on the relationship between IDO and the immune system.
"As a physician that sees firsthand the devastation caused by cancer and viruses, I am extremely excited about our ability to modulate critical immunological pathways using naturally occurring ingredients such as pterostilbene, thymoquinone, epigallocatechin gallate and sulforaphane," said Dr. James Veltmeyer, Chief Medical Officer of the Company and Co-Inventor of the patent. "What is particularly important is that after filing of our patents, numerous independent universities have validated the anti-COVID activity of the individual ingredients. These studies are summarized in our previous press release(4)."
"The acceptance of our data by the United States Patent Office in granting of the current patent is a major accomplishment for the Company," said Timothy Dixon, President and CEO, and Co-Inventor of the patent. "The Company has numerous patent applications filed covering multiple nutraceuticals and uses including; a) published patent application #16/866430 entitled 'Nutraceuticals for the Prevention, Inhibition, and Treatment of SARS-Cov-2 and Associated COVID-19', b) #16/898472 entitled 'Nutraceuticals for Reducing Myeloid Suppressor Cells' and c) #16/907335 entitled 'Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity'."
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/
1 Global Checkpoint Inhibitors Market (2021 to 2030)
2 Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model - Zheng - 2013
3 A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem - Zhang - 2018
4 Therapeutic Solutions International Discusses Claims of Possible COVID-19 Suppressive Activity of QuadraMune(TM) Ingredients by Independent Universities Made After Patent Filing
View source version on businesswire.com: https://www.businesswire.com/news/home/20211228005154/en/
SOURCE: Therapeutic Solutions International
Timothy G. Dixon
ir@tsoimail.com
There is more news coming--soon-- count on it IMHO Quintilly!
TSOI milly BillY TRILLY TSOI Small bomb
December 28, 2021 - 1:17 pm
Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment
https://www.stocktitan.net/news/TSOI/therapeutic-solutions-international-awarded-landmark-patent-for-ku4duunhtds5.html
Longs will be berry berry happy Stay the course (as if longs need to see that) milly BillY TRILLY https://charts.stocktwits.com/production/original_421036374.png
Oldie but a GOODIE -very
MillY bILLY TRillY Gazilly Quintilly YA BABY!
TimGDixon THE MAN "I don't really expect anyone to understand it in its fullness but I am happy to discuss. We have been quietly prosecuting this patent because as we know Operation Warp Speed took over. This invention and its application is as timely as those were. In fact this vaccine is superior to mRNA in many ways and doesn't need to worry about mutations of the sarscov2 genome. In my words, this is a serial killer that kills with extreme prejudice if awakened from b and t cell memory. I should add that this is StemVacs too."
https://board.therapeuticsolutionsint.com/viewtopic.php?p=11839#p11839
TimGDixon THE MAN Fri Dec 24, 2021 5:50 am
Fri Dec 24, 2021 5:50 am
https://board.therapeuticsolutionsint.com/viewtopic.php?t=1436
TimGDixon THE MAN-- DEC 12TH-- "I anticipate enrollments likely starting in early January but even that is subject to change but we are close"
.https://board.therapeuticsolutionsint.com/viewtopic.php?p=11043#p11043